Skip to content

Screening programme for pre-eclampsia

The diagnostic accuracy of pregnant women screened for pre-eclampsia using Bayes theorem based and screening according to NICE guidelines

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN83611527
Enrollment
16850
Registered
2016-07-06
Start date
2016-04-12
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Reproductive health and childbirth, Primary sub-specialty: Reproductive and sexual medicine Pregnancy and Childbirth Pre-eclampsia

Interventions

All participants to attend the 2 study visits (at 11-13 weeks gestation and 19-24 weeks gestation). The final, pregnancy outcome data is retrieved from patient notes so no participant visit is require

Sponsors

Delegated to University College London Comprehensive Clinical Trials Unit (UCL CCTU) by Kings College London
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over 2. Singleton pregnancy 3. Live fetus at 11-13 weeks' gestation 4. Informed and written consent

Exclusion criteria

Exclusion criteria: 1. Women who are severely ill 2. Those with learning difficulties 3. Those with a serious mental illness 4. Pregnancies complicated by major fetal abnormality identified at 11-13 weeks of gestation

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy (false positive and true positive frequencies) of screening for pre-eclampsia using the Bayes theorem based method is measured as the rate of pre-eclampsia, determined using medical note review within one month of birth.

Secondary

MeasureTime frame
Detection rate of pre-eclampsia is measured through medical note review within one month of birth.

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026